|
Market Closed -
Other stock markets
|
Pre-market 09:14:31 pm | |||
| 929.55 USD | -1.06% |
|
931.65 | +0.23% |
| 07:46pm | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 04:01pm | Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development | RE |
| Capitalization | 832B 711B 655B 618B 1,149B 77,885B 1,178B 7,674B 3,017B 37,195B 3,122B 3,055B 132,866B | P/E ratio 2026 * |
27.4x | P/E ratio 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise value | 848B 724B 668B 630B 1,171B 79,375B 1,201B 7,821B 3,075B 37,907B 3,181B 3,114B 135,406B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 8.72x |
| Free-Float |
99.81% | Yield 2026 * |
0.73% | Yield 2027 * | 0.81% |
Last Transcript: Eli Lilly and Company
| 1 day | +0.23% | ||
| 1 week | +0.27% | ||
| Current month | +1.06% | ||
| 1 month | -5.64% | ||
| 3 months | -13.71% | ||
| 6 months | +13.44% | ||
| Current year | -13.50% |
| 1 week | 927.17 |  | 963.94 |
| 1 month | 877.11 | | 998.17 |
| Current year | 877.11 | | 1,133.95 |
| 1 year | 623.78 | | 1,133.95 |
| 3 years | 367.35 | | 1,133.95 |
| 5 years | 178.58 | | 1,133.95 |
| 10 years | 64.18 | | 1,133.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.16% | 6.49% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.06% | +0.27% | +26.92% | +147.78% | 832B | |
| -0.21% | -1.25% | +56.83% | +43.25% | 573B | |
| -0.71% | -0.11% | +17.95% | +26.91% | 365B | |
| +0.30% | -0.75% | +29.45% | +14.12% | 322B | |
| -0.36% | -0.13% | +44.75% | +25.61% | 313B | |
| -1.05% | -0.58% | +51.74% | +3.95% | 297B | |
| -0.65% | +0.13% | +35.18% | +37.18% | 292B | |
| -0.34% | +2.12% | +22.32% | +39.13% | 189B | |
| +0.03% | -0.78% | +34.16% | +66.96% | 173B | |
| +4.06% | +5.44% | -43.12% | -56.68% | 166B | |
| Average | +0.14% | -0.52% | +27.62% | +34.82% | 352.05B | |
| Weighted average by Cap. | -0.07% | -0.60% | +32.27% | +54.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 81.83B 69.91B 64.46B 60.83B 113B 7,662B 116B 755B 297B 3,659B 307B 301B 13,071B | 95.09B 81.23B 74.9B 70.68B 131B 8,904B 135B 877B 345B 4,252B 357B 349B 15,189B |
| Net income | 30.29B 25.87B 23.86B 22.51B 41.84B 2,836B 42.9B 279B 110B 1,354B 114B 111B 4,838B | 36.14B 30.87B 28.47B 26.86B 49.92B 3,384B 51.18B 333B 131B 1,616B 136B 133B 5,772B |
| Net Debt | 15.9B 13.59B 12.53B 11.82B 21.97B 1,489B 22.52B 147B 57.68B 711B 59.68B 58.42B 2,540B | -3.02B -2.58B -2.38B -2.24B -4.17B -283B -4.27B -27.84B -10.94B -135B -11.32B -11.08B -482B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/04/26 | 929.55 $ | -1.06% | 2,089,567 |
| 10/04/26 | 939.47 $ | -1.65% | 1,958,925 |
| 09/04/26 | 955.19 $ | +0.20% | 1,672,549 |
| 08/04/26 | 953.30 $ | +2.39% | 2,567,998 |
| 07/04/26 | 931.09 $ | +0.43% | 2,726,863 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition